NovoCure Ltd — Director's Dealing 2018

Jul 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-07-02

Reporting Person: Ambrogi Michael J. (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-07-02	Ordinary Shares	M	27825	$7.03	Acquired	174383	Direct
2018-07-02	Ordinary Shares	M	29565	$7.48	Acquired	203948	Direct
2018-07-02	Ordinary Shares	S	57390	$31.48	Disposed	146558	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-07-02	Options to Buy Ordinary Shares	$7.03	M	27825	Acquired	2023-02-20	Ordinary Shares (27825)	Direct
2018-07-02	Options to Buy Ordinary Shares	$7.48	M	29565	Acquired	2024-02-26	Ordinary Shares (29565)	Direct

Footnotes

F1: These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi.

F2: On July 2, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 57,390 shares in multiple trades at prices ranging from $31.00 to $31.95. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3: Fully vested as of the date hereof.